The lawsuit, filed Tuesday in U.S. District Court in Delaware, is the latest in a series of patent challenges against ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Earl Bakken works in the original Medtronic garage, then a medical electronics repair shop in Minneapolis, in 1955. (Courtesy of Medtronic) At the time, pacemakers were “crude devices,” with ...
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the ...
According to the evidence presented at trial, Doron Tavlin learned about a secret, pending acquisition by Medtronic of Mazor Robotics, where he worked as vice president of business development ...
The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...
Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...
Friday, November 8, 2024 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Oracle Corp.
Medtronic in Santa Ana says its layoffs would be temporary while it repairs the roof of its medical device-making facility, while Avante Health Solutions in San Clemente hopes to retain its staff ...
Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...